NEW YORK (GenomeWeb) – Foundation Medicine will collaborate with the National Cancer Institute on its Exceptional Responders Initiative to study why some cancer patients have a dramatic response to therapy.

The NCI is leading the study and Baylor College of Medicine and Nationwide Children's Hospital are also collaborating.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.